Atropine Completed Phase 4 Trials for Myopia (Disorder) Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03544827The Effects of Low Dose Atropine on Choroidal Thickness